FMR LLC filings

This page lists the SEC filings reported by FMR LLC.

SEC filings by FMR LLC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2024-04-29FMR LLCTurnstone Biologics Corp.1,386,3236.0%EDGAR
SC 13G/A2024-04-10FMR LLCROKU, INC13,365,70010.6%EDGAR
SC 13G/A2024-04-10FMR LLCHESS CORP7,663,8032.5%EDGAR
SC 13G/A2024-04-10FMR LLCSeer, Inc.706,5991.2%EDGAR
SC 13G/A2024-04-10- ---EDGAR
SC 13G/A2024-04-10FMR LLCRegulus Therapeutics Inc.2,922,6004.5%EDGAR
SC 13G/A2024-04-10FMR LLCSpirit AeroSystems Holdings, Inc.15,445,13013.2%EDGAR
SC 13G/A2024-04-10FMR LLCGRANITE CONSTRUCTION INC1,850,8114.2%EDGAR
SC 13G/A2024-04-10- ---EDGAR
SC 13G/A2024-04-10FMR LLCArcellx, Inc.5,394,49510.2%EDGAR
SC 13G2024-04-10FMR LLCReddit, Inc.14,104,41427.2%EDGAR
SC 13G2024-04-10FMR LLCSTERLING INFRASTRUCTURE, INC.3,453,67911.1%EDGAR
SC 13G2024-04-10FMR LLCBoundless Bio, Inc.3,263,26814.7%EDGAR
SC 13G2024-04-10FMR LLCAltice USA, Inc.29,068,35910.7%EDGAR
SC 13G2024-04-10FMR LLCAstera Labs, Inc.16,403,97110.6%EDGAR
SC 13G/A2024-04-03FMR LLCSana Biotechnology, Inc.22,167,55010.1%EDGAR
SC 13G/A2024-03-11- ---EDGAR
SC 13G/A2024-03-11FMR LLCNXP Semiconductors N.V.25,743,02410.0%EDGAR
SC 13G/A2024-03-11FMR LLCTyra Biosciences, Inc.4,654,27610.8%EDGAR
SC 13G/A2024-03-11FMR LLCSagimet Biosciences Inc.742,3922.4%EDGAR
Form 13F-HR
The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
Form SC 13D/G
Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
Form 3, 4, and 5
Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.